Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Dyslipidemia

Free Subscription Articles published in Am J Cardiol Retrieve available abstracts of 63 articles: HTML format Text format

Single Articles

December 2011
1. ZAMIRIAN M
   What homozygous familial hypercholesterolemia produces and the will to withstand its complications.
   Am J Cardiol. 2011;108:1840-1.
   PubMed     Text format     Related articles   
   
   
   
   September 2011
2. DESHMUKH A , Kumar G, Kumar N, Nanchal R, et al
   Effect of Joint National Committee VII Report on Hospitalizations for Hypertensive Emergencies in the United States.
   Am J Cardiol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. SAMUEL S , Peskin B, Arondekar B, Alperin P, et al
   Estimating health and economic benefits from using prescription omega-3 Fatty acids in patients with severe hypertriglyceridemia.
   Am J Cardiol. 2011;108:691-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. BAYS HE , Ballantyne CM, Kastelein JJ, Isaacsohn JL, et al
   Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial).
   Am J Cardiol. 2011;108:682-90.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
5. HENEGHAN HM , Meron-Eldar S, Brethauer SA, Schauer PR, et al
   Effect of Bariatric Surgery on Cardiovascular Risk Profile.
   Am J Cardiol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. PARK KW , Jeon KH, Kang SH, Oh IY, et al
   Clinical Outcomes of High On-Treatment Platelet Reactivity in Koreans Receiving Elective Percutaneous Coronary Intervention (from Results of the CROSS VERIFY Study).
   Am J Cardiol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. REDDIGAN JI , Ardern CI, Riddell MC, Kuk JL, et al
   Relation of Physical Activity to Cardiovascular Disease Mortality and the Influence of Cardiometabolic Risk Factors.
   Am J Cardiol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. PLUTZKY J
   Macrovascular effects and safety issues of therapies for type 2 diabetes.
   Am J Cardiol. 2011;108.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. DEFRONZO RA , Abdul-Ghani M
   Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.
   Am J Cardiol. 2011;108.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
10. CHIANG CW , Santos RD, Waters DD, Messig M, et al
    Reaching C-reactive protein and low-density lipoprotein cholesterol goals in dyslipidemic patients (from the Lipid Treatment Assessment Project [L-TAP] 2).
    Am J Cardiol. 2011;107:1639-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
11. SHIMONY A , Eisenberg MJ, Rudski LG, Schlesinger R, et al
    Prevalence and Impact of Coronary Artery Disease in Patients With Pulmonary Arterial Hypertension.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. BAYS HE , Davidson MH, Massaad R, Flaim D, et al
    Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study).
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. VYSSOULIS G , Karpanou E, Adamopoulos D, Tzamou V, et al
    Effect of Age on Interdependence and Hierarchy of Cardiovascular Risk Factors in Hypertensive Patients.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. GRUNDY SM , Vega GL, Tomassini JE, Tershakovec AM, et al
    Comparisons of Apolipoprotein B Levels Estimated by Immunoassay, Nuclear Magnetic Resonance, Vertical Auto Profile, and Nonhigh-Density Lipoprotein Cholesterol in Subjects With Hypertriglyceridemia (SAFARI Trial).
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. COTE M , Cartier A, Reuwer AQ, Arsenault BJ, et al
    Adiponectin and Risk of Coronary Heart Disease in Apparently Healthy Men and Women (from the EPIC-Norfolk Prospective Population Study).
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. ELIS A , Zhou R, Stein EA
    Effect of Lipid-Lowering Treatment on Natural History of Heterozygous Familial Hypercholesterolemia in Past Three Decades.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. YUNOKI K , Nakamura K, Miyoshi T, Enko K, et al
    Impact of Hypertriglyceridemia on Endothelial Dysfunction During Statin +/- Ezetimibe Therapy in Patients With Coronary Heart Disease.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
18. SARNO G , Raber L, Onuma Y, Garg S, et al
    Impact of Body Mass Index on the Five-Year Outcome of Patients Having Percutaneous Coronary Interventions With Drug-Eluting Stents.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
19. YAGI S , Akaike M, Aihara KI, Iwase T, et al
    Effect of Low-Dose (1 mg/day) Pitavastatin on Left Ventricular Diastolic Function and Albuminuria in Patients With Hyperlipidemia.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MAKINO K , Yoshitama T, Kanda S, Takasawa Y, et al
    Relation of Coronary Plaque Composition Determined by 64-Slice Multidetector Computed Tomography in Patients With Suspected Coronary Heart Disease.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. ACCAD M
    More reasons statin drugs are shunned.
    Am J Cardiol. 2011;107:957.
    PubMed     Text format     Related articles   
    
    
    
    
22. GOLDBERG AC , Bittner V, Pepine CJ, Kelly MT, et al
    Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
    Am J Cardiol. 2011;107:898-905.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
23. SALISBURY AC , Chan PS, Gosch KL, Buchanan DM, et al
    Patterns and Predictors of Fast Food Consumption After Acute Myocardial Infarction.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. THONGTANG N , Ai M, Otokozawa S, Himbergen TV, et al
    Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.
    Am J Cardiol. 2011;107:387-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
25. KRYSIAK R , Gdula-Dymek A, Okopien B
    Effect of Simvastatin and Fenofibrate on Cytokine Release and Systemic Inflammation in Type 2 Diabetes Mellitus With Mixed Dyslipidemia.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. CHO EJ , Min YJ, Oh MS, Kwon JE, et al
    Disappearance of Angina Pectoris by Lipid-Lowering in Type III Hyperlipoproteinemia.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. CHRISTIAN JB , Bourgeois N, Snipes R, Lowe KA, et al
    Prevalence of Severe (500 to 2,000 mg/dl) Hypertriglyceridemia in United States Adults.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KARALIS DG , Subramanya RD, Hessen SE, Liu L, et al
    Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease.
    Am J Cardiol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. NICHOLS GA , Arondekar B, Garrison LP Jr
    Patient characteristics and medical care costs associated with hypertriglyceridemia.
    Am J Cardiol. 2011;107:225-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
30. MALIK AS , Giamouzis G, Georgiopoulou VV, Fike LV, et al
    Patient Perception Versus Medical Record Entry of Health-Related Conditions Among Patients With Heart Failure.
    Am J Cardiol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. DE GRAAF FR , Schuijf JD, Scholte AJ, Djaberi R, et al
    Usefulness of hypertriglyceridemic waist phenotype in type 2 diabetes mellitus to predict the presence of coronary artery disease as assessed by computed tomographic coronary angiography.
    Am J Cardiol. 2010;106:1747-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. GISONDI P , Farina S, Giordano MV, Girolomoni G, et al
    Usefulness of the framingham risk score in patients with chronic psoriasis.
    Am J Cardiol. 2010;106:1754-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. ENGER C , Gately R, Ming EE, Niemcryk SJ, et al
    Pharmacoepidemiology safety study of fibrate and statin concomitant therapy.
    Am J Cardiol. 2010;106:1594-601.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
34. OTSUKA T , Kawada T, Seino Y, Ibuki C, et al
    Relation of smoking status to serum levels of N-terminal pro-brain natriuretic Peptide in middle-aged men without overt cardiovascular disease.
    Am J Cardiol. 2010;106:1456-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. BLAHA MJ , Budoff MJ, Rivera JJ, Khan AN, et al
    Relation of Aortic Valve Calcium Detected by Cardiac Computed Tomography to All-Cause Mortality.
    Am J Cardiol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. ROBERTS WC
    It's the cholesterol, stupid!
    Am J Cardiol. 2010;106:1364-6.
    PubMed     Text format     Related articles   
    
    
    
    
37. HARRINGTON C , Horne A Jr, Hasan RK, Blumenthal RS, et al
    Statin therapy in primary prevention: new insights regarding women and the elderly.
    Am J Cardiol. 2010;106:1357-9.
    PubMed     Text format     Related articles   
    
    
    
    
38. BHAN V , Yan RT, Leiter LA, Fitchett DH, et al
    Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
    Am J Cardiol. 2010;106:1270-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. FOODY JM , Brown WV, Zieve F, Adewale AJ, et al
    Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults >/=65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Am J Cardiol. 2010;106:1255-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. YUE WS , Wang M, Yan GH, Yiu KH, et al
    Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease.
    Am J Cardiol. 2010;106:1248-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
41. DEMAZUMDER D , Hasan RK, Blumenthal RS, Michos ED, et al
    Should statin therapy be allocated on the basis of global risk or on the basis of randomized trial evidence?
    Am J Cardiol. 2010;106:905-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. FARNIER M , Ducobu J, Bryniarski L
    Efficacy and Safety of Adding Fenofibrate 160 mg in High-Risk Patients With Mixed Hyperlipidemia Not Controlled by Pravastatin 40 mg monotherapy.
    Am J Cardiol. 2010;106:787-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
43. MARK DA
    All red yeast rice products are not created equal-or legal.
    Am J Cardiol. 2010;106:448.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
44. BROWN AS , Cofer-Chase L, Eagan CA
    Linguistic analysis of in-office dialogue among cardiologists, primary care physicians, and patients with mixed dyslipidemia.
    Am J Cardiol. 2010;106:51-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
45. CHIOU KR , Charng MJ
    Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia.
    Am J Cardiol. 2010;105:1752-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. MORIARTY PM , Luyendyk JP, Gibson CA, Backes JM, et al
    Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
    Am J Cardiol. 2010;105:1585-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
47. CICERO AF , Derosa G, Borghi C
    Red yeast rice and statin-intolerant patients.
    Am J Cardiol. 2010;105:1504.
    PubMed     Text format     Related articles   
    
    
    
    
48. GOLLEDGE J , van Bockxmeer F, Jamrozik K, McCann M, et al
    Association between serum lipoproteins and abdominal aortic aneurysm.
    Am J Cardiol. 2010;105:1480-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. AKDIM F , Visser ME, Tribble DL, Baker BF, et al
    Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia.
    Am J Cardiol. 2010;105:1413-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. MAKI KC , Dicklin MR, Davidson MH, Doyle RT, et al
    Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
    Am J Cardiol. 2010;105:1409-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
51. DRAGER LF , Genta PR, Pedrosa RP, Nerbass FB, et al
    Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension.
    Am J Cardiol. 2010;105:1135-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
52. VENERO CV , Venero JV, Wortham DC, Thompson PD, et al
    Lipid-lowering efficacy of red yeast rice in a population intolerant to statins.
    Am J Cardiol. 2010;105:664-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. ZIEVE F , Wenger NK, Ben-Yehuda O, Constance C, et al
    Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study).
    Am J Cardiol. 2010;105:656-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
54. FAZIO S , Guyton JR, Polis AB, Adewale AJ, et al
    Long-Term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin Plus Extended-Release Niacin in Patients With Hyperlipidemia.
    Am J Cardiol. 2010;105:487-494.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
55. HALBERT SC , French B, Gordon RY, Farrar JT, et al
    Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.
    Am J Cardiol. 2010;105:198-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2009
56. BODEN WE , McGovern ME
    Optimal management of persistent mixed dyslipidemia after statin initiation warrants combination therapy.
    Am J Cardiol. 2009;104:1695-6.
    PubMed     Text format     Related articles   
    
    
    
    
57. NICHOLS GA , Ambegaonkar BM, Sazonov V, Brown JB, et al
    Frequency of obtaining national cholesterol education program adult treatment panel III goals for all major serum lipoproteins after initiation of lipid altering therapy.
    Am J Cardiol. 2009;104:1689-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. VEDRE A , Gurm HS, Froehlich JB, Kline-Rogers E, et al
    Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]).
    Am J Cardiol. 2009;104:1613-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2009
59. VERGEER M , Stroes ES
    The pharmacology and off-target effects of some cholesterol ester transfer protein inhibitors.
    Am J Cardiol. 2009;104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. STRANG AC , Hovingh GK, Stroes ES, Kastelein JJ, et al
    The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approaches.
    Am J Cardiol. 2009;104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. NICHOLLS SJ
    High-density lipoprotein and progression rate of atherosclerosis in intravascular ultrasound trials.
    Am J Cardiol. 2009;104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. DEEDWANIA P , Singh V, Davidson MH
    Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
    Am J Cardiol. 2009;104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. DAVIDSON MH
    Focus on HDL as a therapeutic target for CAD risk reduction.
    Am J Cardiol. 2009;104.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: